US 12,454,696 B2
Cutibacterium acnes recombinant phages encoding a human protein
Aymeric Leveau, Paris (FR); Inès Canadas Blasco, Paris (FR); Aurélie Mathieu, Paris (FR); and Antoine Decrulle, Paris (FR)
Assigned to Eligo Bioscience, Paris (FR)
Filed by Eligo Bioscience, Paris (FR)
Filed on Sep. 29, 2023, as Appl. No. 18/478,500.
Application 17/821,940 is a division of application No. 17/518,960, filed on Nov. 4, 2021, granted, now 11,473,093, issued on Oct. 18, 2022.
Application 18/478,500 is a continuation of application No. 17/821,940, filed on Aug. 24, 2022, granted, now 11,840,695.
Claims priority of provisional application 63/109,834, filed on Nov. 4, 2020.
Claims priority of provisional application 63/145,967, filed on Feb. 4, 2021.
Claims priority of provisional application 63/145,969, filed on Feb. 4, 2021.
Claims priority of provisional application 63/109,832, filed on Nov. 4, 2020.
Prior Publication US 2024/0035038 A1, Feb. 1, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61P 17/10 (2006.01); A61K 39/02 (2006.01); A61K 39/05 (2006.01); C12N 9/22 (2006.01); C12N 15/11 (2006.01); C12N 15/76 (2006.01); A61K 39/00 (2006.01); C12N 9/64 (2006.01)
CPC C12N 15/76 (2013.01) [A61K 39/02 (2013.01); A61K 39/05 (2013.01); A61P 17/10 (2018.01); C12N 9/22 (2013.01); C12N 15/11 (2013.01); A61K 2039/53 (2013.01); C12N 9/64 (2013.01); C12N 2310/20 (2017.05); C12N 2795/10343 (2013.01); C12N 2800/101 (2013.01); C12N 2800/80 (2013.01)] 15 Claims
 
1. A recombinant C. acnes phage comprising at least one transgene, wherein said transgene encodes a human protein selected from an antibody, a protein that binds non-covalently to a target, a receptor binding protein, a blood factor, an enzyme, a growth factor, a hormone, an interferon, and a cytokine.